PSA is best outcome predictor
نویسندگان
چکیده
منابع مشابه
Robotic Prostatectomy Has a Superior Outcome in Larger Prostates and PSA Density Is a Strong Predictor of Biochemical Recurrence
Objectives. The aims of this study were to compare the outcomes of robotic assisted laparoscopic prostatectomy (RALP) between patients who had larger (≥75 g) and smaller (<75 g) prostates and to evaluate the performance of PSA density (PSAD) in determining the oncological outcome of surgery. Methods and Materials. 344 patients who underwent RALP at a single institution were included in the stud...
متن کاملPre-radiotherapy PSA level as a predictor.
The recent publication on “pre‐radiotherapy PSA level as a predictor” is very interesting. Tsan et al., con‐ cluded that “in patients with increasing prostate‐specific antigen (PSA) levels following radical prostatectomy (RP), local radiotherapy (RT) should be administered prior to biochemical failure (PSA ≥ 0.2) to ensure good biochemical progression ‐ free survival (bPFS).” It seems that the ...
متن کاملMarket value added and traditional accounting criteria: Which measure is a best predictor of stock return in Malaysian companies
This study tests the hypothesis that market value added (MVA) is more highly associated with stock return (SR) than traditional performance measures. The purpose of this study is to provide empirical evidence on the relative and incremental information content of MVA and traditional performance measures, namely, net income (NI), net operational profit after tax (NOPAT), and earning per shares (...
متن کاملFluid therapy and outcome: balance is best.
The use of intravenous fluids is routine in patients undergoing surgery or critical illness; however, controversy still exists regarding optimum fluid therapy. Recent literature has examined the effects of different types, doses, and timing of intravenous fluid therapy. Each of these factors may influence patient outcomes. Crystalloids consist of isotonic saline or balanced electrolyte solution...
متن کاملProstate-Specific Antigen (PSA) Best Practice Policy
Introduction The Use of PSA for Early Detection of Prostate Cancer The Use of PSA for Pretreatment Staging of Prostate Cancer The Use of PSA in the Posttreatment Management of Prostate Cancer Methods Used in Best Practice Policy Development References PSA Best Practice Policy Task Force Prostate cancer is the most common form of noncutaneous cancer in men in the United States. Despite its preva...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Reviews Clinical Oncology
سال: 2009
ISSN: 1759-4774,1759-4782
DOI: 10.1038/nrclinonc.2009.133